NCT00086268已完成3 期
Non-small Cell Lung Cancer Study US75 (Z-PACT)
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 250
- 试验地点
- 79
研究概览
简要总结
This study will evaluate the effects of an investigational drug in combination with chemotherapy in patients with stage IIIB/IV non-small cell lung cancer. This study will measure the effects of this combination on progression of lung cancer, cancer response to treatments, and development of cancer-related bone lesions.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or Female patients at least of 18 years old
- •Patients with diagnosed non-small cell lung cancer that cannot be treated by surgery
- •Women must not be pregnant or attempting to become pregnant
- •Able and willing to sign informed consent
排除标准
- •Patients with cancer that has spread to the bone
- •Patients with cancer that has spread to the brain who are receiving treatment
- •Patients with kidney disease
- •Patients treated with other investigational drugs
研究组 & 干预措施
Zometa®
Experimental
4mg monthly for 12 months from date of first chemotherapy dose
干预措施: zoledronic acid (Drug)
Zometa®
Experimental
4mg monthly for 12 months from date of first chemotherapy dose
干预措施: Taxotere (Drug)
Zometa®
Experimental
4mg monthly for 12 months from date of first chemotherapy dose
干预措施: Carboplatin (Drug)
研究者
研究点 (79)
Loading locations...
相似试验
Unknown
2 期
Curative Study of Chinese Traditional Medicine to Treat Lung CancerCancerNCT02777788Shanghai University of Traditional Chinese Medicine120
已完成
2 期
Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast CancerBreast CancerNCT01036087M.D. Anderson Cancer Center47
尚未招募
3 期
Effect and Mechanism of TCM-TSKSR on Advanced Colon Cancer: A Randomized Placebo-Controlled Clinical TrialITMCTR1900002315Xiyuan Hospital, China Academy of Chinese Medical Sciences
招募中
不适用
LUNG-05: Investigating Chemotherapy Effectiveness for Non-Small Cell Lung Cancer (NSCLC) Metastatic PatientsNSCLCNCT06576635University of Illinois at Chicago29
终止
2 期
Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung CancerNon Small Cell Lung CancerNCT00509366Duke University101